Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Aeterna Zentaris (AEZS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,072
  • Shares Outstanding, K 16,440
  • Annual Sales, $ 910 K
  • Annual Income, $ -24,960 K
  • 36-Month Beta 0.60
  • Price/Sales 29.88
  • Price/Cash Flow N/A
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.70 +10.59%
on 02/09/18
2.47 -23.89%
on 01/24/18
-0.52 (-21.67%)
since 01/23/18
3-Month
1.70 +10.59%
on 02/09/18
3.25 -42.15%
on 12/21/17
-0.21 (-10.05%)
since 11/22/17
52-Week
0.78 +141.03%
on 05/09/17
3.75 -49.87%
on 04/28/17
-1.27 (-40.32%)
since 02/23/17

Most Recent Stories

More News
Biotech Stocks' Research Reports Released on 22nd Century, Abeona Therapeutics, Acasti Pharma, and Aeterna Zentaris

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on XXII, ABEO, ACST, and AEZS which can be accessed for free by signing up to www.wallstequities.com/registration....

AEZS : 1.88 (-0.53%)
ABEO : 13.45 (+0.75%)
XXII : 2.66 (-2.21%)
ACST : 0.97 (unch)
Zacks.com highlights: Sanchez Midstream Partners, Tecnoglass, Aeterna Zentaris, Ardelyx and Matrix Service

Zacks.com highlights: Sanchez Midstream Partners, Tecnoglass, Aeterna Zentaris, Ardelyx and Matrix Service

AEZS : 1.88 (-0.53%)
SNMP : 10.80 (-0.46%)
MTRX : 15.30 (+0.99%)
ARDX : 5.75 (+4.55%)
TGLS : 8.90 (+0.68%)
5 Great Breakout Stocks Offering Superlative Returns

This method involved zeroing in on those stocks whose prices are varying within a narrow band.

AEZS : 1.88 (-0.53%)
SNMP : 10.80 (-0.46%)
MTRX : 15.30 (+0.99%)
ARDX : 5.75 (+4.55%)
TGLS : 8.90 (+0.68%)
Aeterna Zentaris Enters into Licensing and Assignment Agreement with Strongbridge for Macrilen(TM) (macimorelin) in the U.S. and Canada

Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) announced today that it has, through a wholly-owned subsidiary, entered into a license and assignment agreement with a wholly-owned subsidiary of Strongbridge...

AEZS.TO : 2.36 (-0.84%)
AEZS : 1.88 (-0.53%)
SBBP : 6.55 (-3.68%)
Aeterna Zentaris Provides Update on Litigation against David Dodd and Philip Theodore

Aeterna Zentaris Inc. (the "Company" or "Aeterna Zentaris") (NASDAQ:AEZS) (TSX:AEZS), a specialty biopharmaceutical company engaged in developing and commercializing pharmaceutical therapies, announced...

AEZS.TO : 2.36 (-0.84%)
AEZS : 1.88 (-0.53%)
Aeterna Zentaris Announces Departure of Interim Chief Financial Officer

Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) (the "Company") announced today the departure of the Company's Interim Chief Financial Officer, Jeffrey Whitnell, effective December 7, 2017. The Company...

AEZS.TO : 2.36 (-0.84%)
AEZS : 1.88 (-0.53%)
Biotech's Flying Under The Radar

Biotech investors spend a ton of time considering what the cure for cancer could be or the next invention that could eliminate a rare disease. It's difficult to keep track of the advancements and developments...

ESPR : 78.90 (+1.23%)
AEZS : 1.88 (-0.53%)
PPCB : 0.1205 (-0.41%)
GERN : 2.23 (unch)
CPRX : 3.23 (+2.54%)
Today's Research Reports on Trending Tickers: Aeterna Zentaris and Intercept Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / November 28, 2017 / U.S. markets were mixed Monday as retailers surged on strong holiday sales numbers, while chipmakers and oil stocks dragged. The Dow Jones Industrial Average...

AEZS : 1.88 (-0.53%)
ICPT : 62.04 (+4.18%)
Aeterna Zentaris Reports Third Quarter 2017 Financial and Operating Results

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the "Company"), a specialty biopharmaceutical company engaged in developing and commercializing novel pharmaceutical therapies, today reported...

AEZS.TO : 2.36 (-0.84%)
AEZS : 1.88 (-0.53%)
Aeterna Zentaris to Announce Third Quarter 2017 Financial and Operating Results on November 8, 2017

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the "Company") will announce its third quarter 2017 financial and operating results after market close on Wednesday, November 8, 2017. The...

AEZS.TO : 2.36 (-0.84%)
AEZS : 1.88 (-0.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

See More

Business Summary

AEterna Zentaris Inc. is a biopharmaceutical company focused on endocrine therapy and oncology. Its lead endocrinology program is a Phase 3 trial in benign prostatic hyperplasia (BPH) with cetrorelix, an LHRH antagonist already marketed for in vitro fertilization under the brand name Cetrotide. The lead...

See More

Key Turning Points

2nd Resistance Point 1.94
1st Resistance Point 1.91
Last Price 1.88
1st Support Level 1.85
2nd Support Level 1.82

See More

52-Week High 3.75
Fibonacci 61.8% 2.62
Fibonacci 50% 2.26
Fibonacci 38.2% 1.91
Last Price 1.88
52-Week Low 0.78

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.